“Additional beneficial effects of recombinant growth hormone in alendronate-trated patients with idiopathic osteoporosis”, Actual. Osteol., vol. 6, no. 2, pp. 93–94, Jul. 2024, Accessed: Oct. 11, 2026. [Online]. Available: https://ojs.osteologia.org.ar/aaomm/index.php/osteologia/article/view/509